loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 761064 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 GENENTECH INC (2)

filter

01 SOLUTION;SUBCUTANEOUS (2)

filter

01 Blank (2)

filter

01 RITUXAN HYCELA (2)

filter

01 Blank (2)

URL Supplier Web Content
SOLUTION; SUBCUTAN...
1400MG and 23400UN...
761064
RITUXAN HYCELA
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION; SUBCUTAN...
1600MG and 26800UN...
761064
RITUXAN HYCELA
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 761064

Looking for FDA Orange Book APPLICATION 761064 2

19

Genentech, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT), with a corresponding application number 761064.

With a dosage strength 1400MG and 23400UNITS/11.7ML

Dosage Form Route SOLUTION; SUBCUTANEOUS

18

Genentech, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT), with a corresponding application number 761064.

With a dosage strength 1600MG and 26800UNITS/13.4ML

Dosage Form Route SOLUTION; SUBCUTANEOUS

Post Enquiry
POST ENQUIRY